Anti-Human PLCL1 Polyclonal Antibody

PLC-L (for PLC-deleted in lung carcinoma) is a PLC family memeber, the expression of which is decreased in small cell lung carcinomas. PLC-L is normally expressed in a variety of fetal and adult organs including the lung. PLC-L is thought to be involved in inositol phospholipid-based intracellular signaling cascade and aberrant expression of PLC-L may contributes to the genesis or progression of human lung carcinoma.
List Price: $398
  • Buy 5 for $378.1 each and save 5%
  • Buy 21 for $358.2 each and save 10%
  • Buy 31 for $338.3 each and save 15%
  • Buy 51 for

Properties

Data Sheet Click for Datasheet
Catalog Number PA10719
Size 100μl
Host Type Rabbit
Immunogen Synthetic peptide of human PLCL1
Specificity Expressed in a variety of fetal and adult organs including brain, lung and kidney. Its expression was greatly reduced in small and non-small cell lung carcinoma. Isoform 1 is predominantly expressed in brain.
Isotype IgG
Reacitivity Human
Clone
Uniprot Q15111
Concentration 0.6 mg/mL
Dilution IHC 1:25-1:100
Formulation
Application IHC,ELISA
Other Names Inactive phospholipase C-like protein 1,Inactive protein 1,Phospholipase C deleted in lung carcinoma,Phospholipase C epsilon,Phospholipase C like 1,Phospholipase C related but catalytically inactive protein,Phospholipase C related,but catalytically inactive protein,Phospholipase C-deleted in lung carcinoma,Phospholipase C-related but catalytically inactive protein,Phospholipase C-related catalytically,PLC-L1,PLCE,PLCL,PLCL1,PLCL1,PLDL1,PRIP
Storage Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C.
Postscript For research use only, not for use in diagnostic procedures.

© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap